News IBM Watson, Illumina collaborate on cancer genetics decision... IBM Watson for Genomics will inform cancer treatment decisions by analysing Illumina's genetic data.
News US MCT8 deficiency patients get 1st drug as Emcitate debuts Egetis has launched the first-ever therapy for the ultra-rare disease MCT8 deficiency in the US, with a list price of $950,000 per year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
